Pharmacokinetics and Influence of Arbekacin on Renal Function in Low-Birth-Weight Infants

Kondo, 1973, Syntheses of 1-N-{(S)-4-amino-2-hydoroxybutyryl}-kanamycin B and −3′,4′-dideoxykanamycin B active against kanamycin resistant bacteria, J Antibiot, 26, 410 Inoue, 1994, Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic against methicillin-resistant Staphylococcus aureus, Drugs Exp Clin Res, 20, 233 Hayashi, 1994, Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections, Drugs Exp Clin Res, 20, 225 Fujii, 1994, Clinical of arbekacin sulfate in the pediatric field, Jpn J Antibiot, 47, 57 Kurebe, 1986, Antibacterial activity and ototoxicity in guinea pigs, and nephrotoxicity in rats of arbekacin, Arzneimittel-Forshung, 36, 1511 Langhendries, 1987, Normal values for urinary N-acetyl-beta-glucosaminidase excretion in preterm and term babies, Arch Dis Child, 62, 483, 10.1136/adc.62.5.483 Chen, 1991, Urinary β2-microglobulin and N-acetyl-β-d-glucosaminidase (NAG) as early markers of renal tubular dysfunction in sick neonates, J Formosan Med Assoc, 90, 132 Aoki, 1994, Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin, Jpn J Antibiot, 47, 640 Sakata, 1995, Urinary N-acetyl-β-d-glucosaminidase activity in very-low-birth-weight infants, Acta Neonat Jpn, 31, 254 Gouyon, 1987, Urinary excretion of N-acetyl-glucosaminidase and β-microglobulin as early markers of gentamicin and nephrotoxicity in neonates, Dev Pharmacol Ther, 10, 145, 10.1159/000457739 Langhendries, 1989, Validity of N-acetyl-β-d-glucosaminidase (NAG) determination in assessing netilmicin nephrotoxicity in preterm babies, Biol Neonate, 56, 78, 10.1159/000243105 Milanda, 1985, Gentamicin kinetics in the neonate, Pediatri Pharmacol, 5, 57 Koren, 1985, Optimization of gentamicin therapy in very low birth weight infants, Pediatr Pharmacol, 5, 79 Zarowitz, 1982, High gentamicin trough concentration in neonates of less than 28 weeks gestational age, Dev Pharmacol Ther, 5, 68, 10.1159/000481009